Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Sedation in Orthopedic Surgery
NCT04149626Phase 2Unknown
- Sponsor
- Asklepieion Voulas General Hospital
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in hallux valgus (3 arms), sponsored by Asklepieion Voulas General Hospital. Primary endpoint: Duration of postoperative analgesia at 24 hours. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
hallux valgus
Beyond the preview
Go deeper on NCT04149626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04149626.